Health Highlights: Sept. 3, 2009

Posted: September 3, 2009

Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

One-Dose Swine Flu Vaccine Looks Promising

Hopeful news in the battle against the H1N1 swine flu emerged Thursday as European and Chinese researchers said they have developed swine flu vaccines that work with one dose, rather than two, potentially increasing the supply available for distribution.

Novartis, the Swiss drug maker, found that in a British trial of 100 people between 18 and 50 years old, participants had adequate protection two weeks after just one injection, the Associated Press reported.

In China, a swine flu vaccine was approved on Thursday, which also works with one dose, according to its maker, Sinovac Biotech Ltd.

"The pilot results are encouraging," Andrin Oswald, CEO of Novartis Vaccines and Diagnostics, said in a statement. "This is important information for public health authorities who prepare for vaccination in the coming months with limited vaccine supply."

Scientists previously thought two doses would be necessary, which could have contributed to a vaccine shortage. The World Health Organization declared swine flu a pandemic in June, and last month it said efforts to create an effective vaccine were progressing slowly, which could limit supplies this fall, when a resurgence of swine flu is expected.

Although encouraged, health experts said additional trials of both vaccines are needed to determine if a single dose is enough. How these developments will affect the worldwide supply is still unclear, because Novartis' vaccine relies on cell culture, while most flu vaccines use chicken eggs.

The Novartis formula, like most European vaccines, also uses adjuvants, a chemical component intended to make the vaccine more efficient. Neither the United States nor Canada has licensed flu vaccines with adjuvants, and limited information exists on how they affect pregnant women and children, two groups considered at high risk in a pandemic, the AP said.

The Sinovac vaccine and some others being tested in China and the United States do not use adjuvants.

-----

Many Employer-Based Health Plans Now Cost $20,000-Plus

In 2008, one in 10 workers in three states -- Alaska, Indiana and Minnesota -- was in employer-based family health insurance plans with costs that topped $20,000, according to new data from the Agency for Healthcare Research and Quality.

In a new release, the agency said these costs were at least $7,000 more than the national average. And for the nation as a whole, 10 percent of workers (about 2 million people) had a family health insurance plan costing $17,000 or more. Overall, the average American family paid premiums totaling $12,298 in 2008, the AHRQ said.

Other 2008 data from the agency's analysis of private, employer-based plans:

-----

Detroit Leads Nation in Teen Births: Report

Detroit and Cleveland hold the dubious distinction of landing at the top of the list of U.S. cities with the highest rates of teen births, according to data from the National Center for Health Statistics and other sources. The data was tabulated in 2006, the latest year for which information is available.

As reported in the 2009 edition of Child Trends' Facts at a Glance, 20 percent of births in the Motor City were to women under the age of 20, while Cleveland came in second place with 19 percent of all births occurring among teen moms. Jackson, Miss., and Memphis, Tenn., followed with 18 percent.

Health Professionals Won't Take The Shot!

Prison Planet.com

September 2, 2009

The Centers for Disease Control and Prevention asked neurologists to report cases of Guillain-Barre syndrome, it causes paralysis and breathing difficulties and is sometimes fatal. It also weakens limbs! The swine flu vaccine is being rushed through safety procedures and governments have provided pharmaceutical companies with blanket immunity from lawsuits arriving out of the vaccine causing deaths and injuries.It was revealed some batches of the vaccine contain mercury, a toxin linked with autism and neurological disorders. The vaccine also contains the ingredient squalene and a host of other debilitating diseases.Surveys show multitudes of health professionals refuse to take the vaccine!

Paul Revere of TX @ Sep 03, 2009 16:18:36 PM

H1N1 Vaccine

After seeing the way these drug companies operate with TRYING to tell us MERCURY is okay... IT"S NOT. I will NEVER take ANY vaccine again. Don't take the vaccine it IS deadly.

David Kearns of CA @ Sep 03, 2009 15:11:37 PM

H1N1 vaccine

I'm sick of news reports of vaccine development with NO reference to what formula vaccine they are reporting on! How was the antigen produced? How much antigen was necessary to induce immunity? Did they use an adjuvant, and if so what kind?

This report is absolutely useless, and potentially harmful without such details.

Fail.

Josh of TX @ Sep 03, 2009 14:33:42 PM

Add Your Thoughts
About You

advertisement

U.S. News Rankings & Research

Best Hospitals

See the best hospitals, and the best children's hospitals, in specialties from cancer to urology.

Best Health Plans

U.S. News and NCQA review over 700 health insurance plans in the Best Health Plan rankings.

Best Nursing Homes

The Best Nursing Homes rankings feature data on 15,000-plus homes. Search for one near you.

Diseases & Conditions

Get information on preventing, treating, and managing diseases and conditions. Centers:

advertisement

Sponsored Poll

What factor do you think is responsible for the majority of teen-driving crashes?

View Results

advertisement

Subscribe

U.S. News Digital Weekly

A weekly insider's guide to politics and policy — in a multimedia, digital format. 52 issues for $19.95!

U.S. News & World Report

6 months of U.S. News & World Report's print edition for only $15. Save up to 67% off the cover price!